I. Aaron Davis

Affiliations

  • at Tango Therapeutics Inc. (TNGX), 2024-11-08
  • at Iteos Therapeutics Inc. (ITOS), 2024-06-14
  • at Tyra Biosciences Inc. (TYRA), 2024-02-08
  • Director at Rain Oncology Inc. (RAIN), 2024-01-26
  • at Mirati Therapeutics Inc. (MRTX), 2024-01-25
  • Large Shareholder, Director at Odonate Therapeutics Inc. (ODT), 2021-11-20
  • Other at Pmv Pharmaceuticals Inc. (PMVP), 2020-09-29
  • Large Shareholder at Pandion Therapeutics Inc. (PAND), 2020-07-21
  • Large Shareholder at Aradigm Corp (ARDM), 2013-05-30
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
RAIN $5.83 972,212 $5,667,995.96 2,147,212 2022-11-04 Filing
ITOS $32.85 20,000 $656,980.00 3,192,058 2022-03-23 Filing
ITOS $33.43 5,000 $167,139.00 3,172,058 2022-03-22 Filing
ITOS $33.09 3,700 $122,432.26 3,167,058 2022-03-22 Filing
ITOS $31.88 21,300 $678,937.50 3,163,358 2022-03-22 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
ITOS $18.25 337,109 $6,151,801.01 2,154,058 2022-05-11 Filing
ITOS $17.53 891 $15,621.01 2,491,167 2022-05-11 Filing
ITOS $24.77 4,850 $120,111.71 2,492,058 2022-05-10 Filing
ITOS $25.18 95,150 $2,395,857.97 2,496,908 2022-05-10 Filing
ITOS $23.47 200,000 $4,693,120.00 2,592,058 2022-05-09 Filing